A number of research firms have changed their ratings and price targets for Werewolf Therapeutics (NASDAQ: HOWL): 6/4/2024 – Werewolf Therapeutics had its “market outperform” rating reaffirmed by analysts at JMP Securities. They now have a $12.00 price target on the stock. 6/3/2024 – Werewolf Therapeutics had its “outperform” rating reaffirmed by analysts at Wedbush. […]
Creative Planning raised its holdings in Vanguard Mid-Cap ETF (NYSEARCA:VO – Free Report) by 0.7% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 8,338,944 shares of the company’s stock after purchasing an additional 60,455 shares during the period. Vanguard Mid-Cap ETF […]
Creative Planning grew its stake in shares of Schwab International Equity ETF (NYSEARCA:SCHF – Free Report) by 5.4% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 22,058,424 shares of the company’s stock after purchasing an additional 1,130,219 shares during the period. Schwab […]
XML Financial LLC grew its position in Vanguard Mid-Cap ETF (NYSEARCA:VO – Free Report) by 2.3% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 25,673 shares of the company’s stock after purchasing an additional 574 shares during the quarter. XML Financial LLC’s holdings […]
1832 Asset Management L.P. lowered its position in Vanguard Mid-Cap ETF (NYSEARCA:VO – Free Report) by 6.2% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 498,939 shares of the company’s stock after selling 32,922 shares during the period. 1832 Asset Management […]